Susquehanna International Group
ONCS

Susquehanna International Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Susquehanna International Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-941
Closed -$44K – 14530
2021
Q3 		$44K Buy
+941
New +$47.7K ﹤0.01% 12393

Other funds holding ONCS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's ONCS Position: Q4 2022 in Review

Susquehanna International Group sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 2,829 shares — an estimated $30K sold.

Susquehanna International Group first reported a position in ONCS in Q4 2016 and held it in 8 quarters. The position peaked at $76K in Q1 2022. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

  • Susquehanna International Group reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 2,829 OncoSec Medical Incorporated shares in Q4 2022, an estimated $30K.
  • Susquehanna International Group first reported a position in OncoSec Medical Incorporated in Q4 2016 and held it in 8 quarters.
  • Susquehanna International Group's OncoSec Medical Incorporated position peaked at $76K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.